A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a potentially curative treatment for multiple myeloma (MM); however, due to high-treatment related mortality (TRM) its role is not well defined. METHODS: Patients with newly diagnosed, relapsed, or primary refractory myelom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bashir, Qaiser, Khan, Hassan, Thall, Peter F, Liu, Ping, Shah, Nina, Kebriaei, Partow, Parmar, Simrit, Oran, Betul, Ciurea, Stefan, Nieto, Yago, Jones, Roy, Hosing, Chitra M, Popat, Uday R, Dinh, Yvonne T, Rondon, Gabriela, Orlowski, Robert Z., Shah, Jatin J, De Lima, Marcos, Shpall, Elizabeth, Champlin, Richard, Giralt, Sergio, Qazilbash, Muzaffar
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4157818/
https://ncbi.nlm.nih.gov/pubmed/23872222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.07.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados